About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
2022 NCCN Guidelines Updates on MRD Testing in ALL
By
Jonathan Webster
2 Videos
149 views
September 21, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
09:51
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
Feat.
N. S. Raje
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Immunotherapies in Acute Leukemias: 2024 Update
Feat.
C. Lai
04:02
Michael Burke
Updated Results from the BLAST and TOWER Studies: Safety and Efficac…
28:07
Indy Hematology Review
Controversies and Recommendations for the Treatment of ALL and Lymph…
Feat.
W. Stock
31:00
Louisville Hematology Highlights
Current Approaches in the Frontline Treatment of Adult ALL
Feat.
N. Short
48:05
Yale Cancer Center
ALL - Progress in Research and Therapy in 2022
Feat.
H. Kantarjian
18:39
Fred Hutchinson Cancer Center
MRD Positivity in ALL: Next Steps in Clinical Approach
Feat.
R. Cassaday
08:22
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 First Report of Phase 3 PhALLCON Study: Comparing Ponatini…
Feat.
E. Jabbour
10:16
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: ALL
Feat.
E. Jabbour
16:14
Hugo Akabane
Importance of Early Intervention in MRD+ ALL
20:29
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Slow-Motion Therapeutic Revolution in Adult ALL
Feat.
H. Kantarjian
15:23
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Updates on the Role of SCT in ALL in the Era of CAR-T
Feat.
J. Park
20:23
Cedars Sinai
MRD in ALL: Testing Methods and How to Respond to Presence or Absenc…
Feat.
N. Merin
20:28
Insights from 2023 ASH Annual Meeting
Clinically-Relevant Updates in ALL in Adults From ASH 2023
Feat.
R. Cassaday
10:21
Nicholas Short
Eliminating MRD Prior to HSCT in ALL: Strategies and Considerations
10:33
Lori Muffly
Next Questions: ALL
05:27
Penn Medicine Abramson Cancer Center
Treatment Strategies in ALL: Journey to MRD Negativity
Feat.
C. Lai
14:49
Penn Medicine Abramson Cancer Center
The Direction of Leukemia Treatment Nationally and Around the World:…
Feat.
S. Luger
06:36
Indy Hematology Review
Indy Hematology Review 2023: Recent Important Results for Adult ALL
Feat.
C. Schiffer
11:51
Emily Curran
Eliminating MRD in Adults With ALL Prior to Transplant: Practical Ap…
